Who invested in Altay Therapeutics, Inc.?
Altay Therapeutics, Inc.'s investors include HealthCap, Sound Bioventures, Fountain Healthcare Partners, Pappas Capital and Global BioAccess Fund, and 1 more on record. HealthCap led its latest round.
United States · Series A startup
One round we have observed, with the 6 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised this month
Funding summaryUpdated 26 Oct 2026
$37Mraised across 1 round since 2026, from 3 sources
Reported by Sound Bioventures and 2 othersSEC filing: $16M sold, first sale Oct 2026
Altay Therapeutics, Inc.'s investors include HealthCap, Sound Bioventures, Fountain Healthcare Partners, Pappas Capital and Global BioAccess Fund, and 1 more on record. HealthCap led its latest round.
Altay Therapeutics, Inc. has raised $37M across 1 round since 2026.
Altay Therapeutics, Inc.'s most recent round was a Series A of $37M in Oct 2026, led by HealthCap.
Its most recent round, $37M in Oct 2026, is also its largest on record.
Altay Therapeutics, Inc.'s first round on record, in Oct 2026, was backed by HealthCap, Sound Bioventures and Fountain Healthcare Partners and 3 others.
Altay Therapeutics, Inc.'s latest named round is a Series A, in Oct 2026.
Altay Therapeutics, Inc. is based in the United States.
HealthCap led the Series A in 2026.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.